Karen Murry
Karen Murry is the acting director of the US Office of Nonprescription Drugs, where she advocates for the timely approval of new over-the-counter products, including the recent proposal to allow the use of Bemotrizinol in sunscreens, which is seen as a significant enhancement for consumer health and safety.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United Kingdom | 1 | 7.00 | 0.05% | +0% | 67,886,011 | 32,559 | $2,700,000 | 1,295$ |
| Totals | 1 | 67,886,011 | 32,559 | $2,700,000 | 1,295$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Karen Murry, the acting director of the US Office of Nonprescription Drugs, called the inclusion of Bemotrizinol 'a welcome addition' for US consumers.
7